ADAR1 CAPITAL MANAGEMENT, LLC purchased 15.9% of their position (770.33K shares) of TENAX THERAPEUTICS, INC. on the open market
Open‑market purchase worth $1.38M — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/2/2026ACC: 0001940272-26-000019
10% Owner
Since Aug 2026
+770.33K
Net shares
Net buyer
$1.38M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
770.33K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+403.57K
Price / share
$1.79
Trade value
$722.59K
% of position
8.3%
8/31/2026
4.85M→5.26M
Common Stock
Indirect
Shares
+179.06K
Price / share
$1.80
Trade value
$321.57K
% of position
3.4%
9/1/2026
5.26M→5.44M
Common Stock
Indirect
Shares
+187.70K
Price / share
$1.80
Trade value
$337.59K
% of position
3.5%
9/2/2026
5.44M→5.62M
Total
Net shares
+770.33K
Net value
$1.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/31/2026 | P · Purchase | +403.57K | $1.79 | $722.59K | 8.3% | 4.85M | 5.26M |
| Common Stock Indirect | 9/1/2026 | P · Purchase | +179.06K | $1.80 | $321.57K | 3.4% | 5.26M | 5.44M |
| Common Stock Indirect | 9/2/2026 | P · Purchase | +187.70K | $1.80 | $337.59K | 3.5% | 5.44M | 5.62M |
| Total | +770.33K | $1.38M | ||||||
Derivative Transactions0
No derivative transactions reported